Page last updated: 2024-11-12
4-nitro-3-(octanoyloxy)benzoic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 20112083 |
SCHEMBL ID | 7827434 |
MeSH ID | M0272844 |
Synonyms (10)
Synonym |
---|
benzoic acid, 4-nitro-3-[(1-oxooctyl)oxy]- |
55894-52-5 |
SCHEMBL7827434 |
4-nitro-3-(octanoyloxy)benzoic acid |
DTXSID80602602 |
4-nitro-3-octanoyloxybenzoic acid |
4-nitro-3-octanoyloxy-benzoic acid |
4-nitro-3-[(1-oxooctyl)oxy]benzoic acid |
AS-82958 |
4-nitro-3-[(1-oxooctyl)oxy]benzoicacid |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 18.06
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (18.06) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (20.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (80.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |